Interviews

Melanie Dodd, PharmD, PhC, BCPS, discusses the benefits of fiber supplements for patients managing chronic diseases.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, lists some factors that may contribute to the likelihood of a patient with diabetes needing to be readmitted.

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, outlines how pharmacists can optimize their role in creating hospital discharge plans for diabetes patients.

Jeff Goad, PharmD, MPH, details what pharmacists should know about traveler's diarrhea.

Katie Traylor, a PGY2 pharmacy resident in ambulatory care and family medicine, outlines the major glucose monitoring counseling points pharmacists can offer to patients prior to discharge.

Jeff Goad, PharmD, MPH, discusses the benefits of Pepto-Bismol for traveler's diarrhea.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, describes the major glucose monitoring counseling points pharmacists should offer to patients prior to discharge.

Jeff Goad, PharmD, MPH, discusses OTC heartburn relief for travelers.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, describes how certain blood glucose monitors are designed to cater to certain health populations.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses initiatives to optimize medication adherence.

Grant E. Knowles, vice president of business development at Ardon Health, discusses how biosimilars may impact the high cost of specialty drugs.

Marc O'Connor, chief operating officer of Curant Health, discusses how the transition to value-based care can be optimized for specialty stakeholders.

Gregory R. Morris, chief commercial officer at VirMedica, discusses how eAccess can benefit patients and providers.

Deborah Michaelson, MS, RPh, discusses the elements of an ideal specialty pharmacy therapy management program.

Marc O'Connor, chief operating officer of Curant Health, discusses efficiency in specialty pharmacy relationships.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, provides some key takeaways for pharmacists on atrial fibrillation management.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about patient-specific factors to consider when selecting a novel oral anticoagulant.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient's renal function and comorbidities affect dosing regimens for novel oral anticoagulants.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses how to improve adherence.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses why it is important that patients know which medication they should use in a particular situation.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses some ways pharmacists can improve patient adherence to novel oral anticoagulants.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses counseling points for both anticoagulant classes.

Dennis Williams, PharmD, FAPhA, discusses the steps pharmacists should take when a patient does not see relief from first-line therapies.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses counseling points pharmacists should make when demonstrating proper inhaler use.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what patients should consider food-wise when taking vitamin K antagonists or novel oral anticoagulants.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses how new technology is changing the inhaler manufacturing industry.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.